Can a simple device accurately track muscle paralysis in the ICU?
NCT ID NCT07741851
First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time
Summary
This study evaluates how reliably a device monitors neuromuscular blockade (temporary muscle paralysis) in adult intensive care patients. The goal is to see if the device's readings match the expected response in patients without paralysis, and whether using it helps avoid complications like breathing difficulties. Researchers will compare different stimulation methods and track safety over 24-hour periods. The findings could improve how ICU teams monitor and manage muscle relaxants.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- neuromuscular blockade monitoring using the TOFscan Idmed device
- What this could lead to
- If reliable, this monitoring method could help ICU teams better manage muscle paralysis, reducing risks and improving patient safety.
- What could go wrong
- The study is observational and may not capture all clinical variations. Device readings might not always match real conditions, and results may not apply to all ICU patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROMUSCULAR BLOCKADE MONITORING are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Hospitalier Intercommunal Aix-Pertuis
RECRUITINGAix-en-Provence, 13090, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.